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Aspergillus are ﬁlamentous fungi which colonize the respiratory tract of patients
with cystic ﬁbrosis (CF). As a consequence of colonization, sensitization to As-
pergillus can induce allergic bronchopulmonary aspergillosis (ABPA). The objective
of this study was to evaluate the clinical value of Aspergillus detection in the
management of patients with CF.
208 sputum obtained from 84 patients with CF from the CF Centers of Rennes
Brittany, France, were analyzed during a 6 month-prospective study. Aspergillus
detection was performed both by mycological culture and by quantitative PCR
using 2 sets of primers targeting the rRNA 5.8s and A. fumigatus mitochondrial
RNA.
Among patients without ABPA, 51% were colonized by A. fumigatus, either by
classic mycological culture or by PCR. Beside, 50% of patients with classic
ABPA diagnostic criteria (clinical ﬁndings, immediate hypersensitivity skin test
for A. fumigatus, total and A. fumigatus speciﬁc serum IgE, anti-Aspergillus
precipitins, eosinophil count) showed a positive detection of Aspergillus positive.
The correlation between mycological culture and quantitative PCR reached 91.8%.
A lower sensitivity of mycological culture was observed in patients with ABPA
receiving an antifungal treatment. Aspergillus detection in the sputum of patients
suffering from CF without ABPA is a useful and non-invasive tool for the early
characterization of patients at risk for sensitization. During ABPA, Aspergillus
detection is an obvious marker of antifungal treatment failure when it is institued
and must incite practitioner to investigate several causes of failure.
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Introduction: Allergic Bronchopulmonary Aspergillosis (ABPA) is a hypersensi-
tivity reaction to Aspergillus fumigatus and a complication of CF, the treatment of
which is based on the use of systemic steroids. In patients with serious complications
from corticosteroids or in refractory to corticosteroids ABPA, the use of antifungal
agents contributes to the discontinuation or the reduction of steroids.
Purpose: To describe the tolerability of voriconazole as well as its results in the
treatment of ABPA in CF patients.
Material and Methods: In our center, we treated 10 ABPA patients aged between
5−20 years old (mean age: 14 years, males: 7, females:3) with voriconazole (dose:
8mg/kg/24 h, maximum: 400mg) for a period of >6 months.
Results: 5 of our children presented photosensitivity/exanthema, 2 of them pre-
sented also exfoliative dermatitis. 5 of the patients presented elevation of the
hepatic enzymes, mainly of g-gt. One of them with serious elevation of the hepatic
enzymes presented improvement of the hepatic function after diminishing the
dose of voriconazole and when we restarted the full-dose of the antifungal agent
the aforementioned side effect did not reappear. One of the patients presented
disturbances of vision (bright spots) and another headaches at the beginning of the
treatment.
Conclusions: The use of voriconazole was safe, and was associated with transient
side effects in 6 out of the 10 children.
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The airways of cystic ﬁbrosis patients are susceptible to colonisation by fungal
pathogens. The most signiﬁcant of these is Aspergillus fumigatus, which can lead
to the development of allergic bronchopulmonary aspergillosis. Previous studies
have explored prevalence and impact on patient health of both A. fumigatus and
other fungal species known to colonise CF sputum, such as Candida albicans.
However, to date, such studies of fungal species in isolation have failed to address
an important factor. The CF airway is typically colonised by a complex array
of bacterial species. This bacterial community can profoundly inﬂuence, and be
inﬂuenced by, the presence of fungal species. For example, pseudomonads are
known to be capable of producing a wide range of compounds that inﬂuence the
behaviour of fungal species, both positively and negatively. Increasingly, evidence
is emerging that suggests chemical signalling pathways may exist between fungi
and bacteria.
In this study we used molecular proﬁling techniques to determine both the bacterial
and fungal composition of sputum samples from 14 adult CF patients. T-RFLP,
based on the 16S and 18S ribosomal RNA genes, was used to proﬁle the bacterial
and fungal communities respectively. Initial data suggests fungal pathogens are
particularly prevalent in patients with low diversity bacterial populations. Further,
there is a marked separation between detection of fungal pathogens in the CF
airways, which is common, and the presence of signiﬁcantly large colonisations,
which is relatively rare. These data highlight the possibility of important fungal–
bacterial interactions in vivo and underline the need for further investigation in this
area.
194 Emergence and spread of a phylogenetic cluster of
Corynebacteria in cystic ﬁbrosis patients
C. Cassagne1, F. Bittar1, A. Toro1, N. Stremler2, J.C. Dubus2, J. Sarles2,
D. Raoult1, J.M. Rolain1. 1URMITE UMR 6236, CNRS-IRD, Faculte´ de Me´decine
et de Pharmacie, Marseille, France; 2De´partement des Maladies Respiratoires,
CRCM Enfants, Marseille, France
We report in this study 12 cases of Cystic Fibrosis (CF) patients eventually colonized
or infected with Corynebacterium pseudodiphteriticum/propinquum in our reference
centre for children.
The sputa were collected from children and adults CF reference center at Marseille
(France). Sixteen Corynebacteria strains were isolated from 12 children sputum
samples and none from adults. Among twelve patients, seven were associated with
cough. All the strains were identiﬁed by phenotypic methods (Api Coryne database
system 2.0) and by 16SrRNA and partial rpoB gene sequencing. Fifteen Corynebac-
teria belong to the Corynebacterium pseudodiphtericum/propiquum cluster with a
conﬁdence level >98% whereas one strain could not be identiﬁed correctly by gene
sequencing and may represent a new Corynebacterium species.
Corynebacterium were never reported in CF patients probably because these bacteria
are usually considered as contaminant of culture of sputum samples. Furthermore
different closely related Corynebacteria were isolated during time in the same
patient suggesting a mixed colonization and/or infection. The signiﬁcance of the
isolation of these bacteria known to cause various pulmonary diseases and being a
part of the normal microﬂora of the higher respiratory tract remains unclear but may
contribute to the progression of the disease. Epidemiological and clinical studies
are warranted to deﬁne the role of these bacteria in the progression of CF disease.
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